A library of novel naproxen based 1,3,4-oxadiazole derivatives (8–16 and 19–26) has been synthesized and screened for cytotoxicity as EGFR inhibitors. Among the synthesized hybrids, compound2-(4-((5-((S)-1-(2-methoxynaphthalen-6-yl)ethyl)-1,3,4-oxadiazol-2-ylthio)methyl)-1H-1,2,3-triazol-1-yl)phenol(15) was the most potent compound against MCF-7 and HepG2cancer cells with IC₅₀ of 2.13 and 1.63 µg/mL, respectively, and was equipotent to doxorubicin (IC₅₀ 1.62 µg/mL) towards HepG2. Furthermore, compound 15 inhibited EGFR kinase with IC₅₀ 0.41 μM compared to standard drug Erlotinib (IC₅₀ 0.30 μM). The active compound induces a high percentage of necrosis towards MCF-7, HePG2 and HCT 116 cells. The docking studies, DFT and MEP also supported the biological data. These results demonstrated that these synthesized naproxen hybrids have EGFR inhibition effects and can be used as leads for cancer therapy.

A library of 1,2,3-triazole-incorporated thymol-1,3,4-oxadiazole derivatives (6–18) hasbeen synthesized and tested for anticancer and antimicrobial activities. Compounds 7, 8, 9, 10, and 11 exhibited significant antiproliferative activity. Among these active derivatives, compound 2-(4-((5-((2-isopropyl-5-methylphenoxy)methyl)-1,3,4-oxadiazol-2-ylthio)methyl)-1H-1,2,3-triazol-1-yl)phenol (9) was the best compound against all three tested cell lines, MCF-7 (IC₅₀ 1.1 μM), HCT-116 (IC₅₀ 2.6 μM), and HepG2 (IC₅₀ 1.4 μM). Compound 9 was found to be better than the standard drugs, doxorubicin and 5-fluorouracil. These compounds showed anticancer activity through thymidylate synthase inhibition as they displayed significant TS inhibitory activity with IC₅₀ in the range 1.95–4.24 μM, whereas the standard drug, Pemetrexed, showed IC₅₀ 7.26 μM. The antimicrobial results showed that some of the compounds (6, 7, 9, 16, and 17) exhibited good inhibition on Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). The molecular docking and simulation studies supported the anticancer and antimicrobial data. It can be concluded that the synthesized 1,2,3-triazole tethered thymol-1,3,4-oxadiazole conjugates have both antiproliferative and antimicrobial potential.

The casting and preparation of ultrafiltration ZnO modified cellulose acetate membrane (CA/ZnO) were investigated in this work. CA membranes were fabricated by phase inversion using dimethylformamide (DMF) as a solvent and ZnO as nanostructures materials. Ultrafiltration (UF) performance, mechanical stability, morphology, contact angle, and porosity were evaluated on both CA- and ZnO-modified CA samples. Scanning electron microscopy (SEM) was used to determine the morphology of the membranes, showing different pore sizes either on rough surfaces and cross-sections of the samples, an asymmetric structure and ultra-scale pores with an average pore radius 0.0261 to 0.045 µm. Contact angle measurements showed the highest hydrophobicity values for the samples with no ZnO addition, ranging between 48° and 82.7° on their airside. The permeability values decreased with the increasing CA concentration in the casting solution, as expected; however, ZnO-modified membranes produced lower flux than the pure CA ones. Nevertheless, ZnO modified CA membranes have higher surface pore size, pore density and porosity, and improved surface hydrophilicity compared with pure CA membranes. The results indicated that the incorporated nano-ZnO tends to limit the packing of the polymer chains onto the membrane structure while showing antifouling properties leading to better hydrophilicity and permeation with consistent UF applications.

This work aimed to investigate the degradation performance of natural cellulose acetate (CA) membranes filled with ZnO nanostructures. Photocatalytic degradation of reactive toxic dye methylene blue (MB) was studied as a model reaction using UV light. A CA membrane was previously casted and fabricated through the phase inversion processes and laboratory-synthesized ZnO microparticles as filler. The prepared membrane was characterized for pore size, ultrafiltration (UF) performance, porosity, morphology using scanning electron micrographs (SEM), water contact angle and catalytic degradation of MB. The prepared membrane shows a significant amount of photocatalytic oxidation under UV. The photocatalytic results under UV-light radiation in CA filled with ZnO nanoparticles (CA/ZnO) demonstrated faster and more efficient MB degradation, resulting in more than 30% of initial concentration. The results also revealed how the CA/ZnO combination effectively improves the membrane’s photocatalytic activity toward methylene blue (MB), showing that the degradation process of dye solutions to UV light is chemically and physically stable and cost-effective. This photocatalytic activity toward MB of the cellulose acetate membranes has the potential to make these membranes serious competitors for removing textile dye and other pollutants from aqueous solutions. Hence, polymer–ZnO composite membranes were considered a valuable and attractive topic in membrane technology.

The focus of the present work is to evaluate the interactions of an anti-allergic drug (diphenhydramine hydrochloride, DPH) with anionic (sodium dodecyl sulfate, SDS) and cationic (cetylpyridinium chloride, CPC) surfactants in the aqueous medium. The mixed micellization behavior and surface properties of drug-surfactant mixtures have been examined by surface tension measurements. Various theoretical approaches were applied to explore the synergistic or non-ideal behavior of the current mixed systems. Furthermore, the binding studies of drug with surfactants have been elaborated by UV–visible spectroscopy. Benesi–Hildebrand (B-H) theory was used to compute stoichiometric ratio, binding constant, and free energy change for the drug-surfactant mixtures. The outputs are deliberated taking into consideration the use of surfactants as capable drug delivery agents for DPH and hence advance bioavailability.

Carbon dioxide (CO₂) photoreduction into renewable fuels over semiconductor photocatalysts has emerged as a green and sustainable alternative for energy production. Consequently, tremendous efforts are being performed to develop robust and sustainable photocatalysts. Therefore, visible-light active nanocomposite photocatalysts composed of 5.0–20.0 wt.% bismuth oxide (Bi₂O₃) and cerium oxide (CeO₂) were synthesized by a sol-gel-based process. The prepared nanocomposites were evaluated for the promoted photocatalytic reduction of CO₂ into methanol (CH₃OH). Various characterizations of the obtained photocatalysts exposed an outstanding development of crystalline structure, morphology, and surface texture due to the presence of Bi₂O₃. Moreover, the absorbance of light in the visible regime was improved with enhanced charge separation, as revealed by the exploration of optical response, photoluminescence, and photocurrent measurements. The overall bandgap calculations revealed a reduction to 2.75 eV for 15% Bi₂O₃/CeO₂ compared to 2.93 eV for pure CeO₂. Moreover, the adjusted 2.8 g L⁻¹ dose of 15% Bi₂O₃/CeO₂ selectively produced 1300 μmol g⁻¹ CH₃OH after 9 h of visible light irradiation. This photocatalyst also exhibits bearable reusability five times. The improved progression of 15% Bi₂O₃/CeO₂ is denoted by significant charge separation as well as enhanced mobility. This study suggests the application of metal oxide-based heterojunctions for renewable fuel production under visible light.